• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Genworth Financial Inc

    5/28/25 4:16:43 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    S-8 1 d948767ds8.htm S-8 S-8

    As filed with the Securities and Exchange Commission on May 28, 2025.

    Registration No. 333-   

     

     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    LOGO

    GENWORTH FINANCIAL, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   80-0873306

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

    11011 West Broad Street

    Glen Allen, Virginia 23060

    (Address, including Zip Code, of Principal Executive Offices)

    2025 Genworth Financial, Inc. Omnibus Incentive Plan

    (Full title of the plan)

    Gregory S. Karawan, Esq.

    Executive Vice President and General Counsel

    Genworth Financial, Inc.

    11011 West Broad Street

    Glen Allen, Virginia 23060

    (804) 281-6000

    (Name, address and telephone number of agent for service)

    Copies to:

    John B. Shannon

    Alston & Bird LLP

    1201 West Peachtree Street, NW

    Atlanta, GA 30309-3424

    (404) 881-7000

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☒    Accelerated filer   ☐
    Non-accelerated filer   ☐    Smaller reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     
     


    EXPLANATORY NOTE

    Genworth Financial, Inc. (the “Company” or the “Registrant”) has filed this Registration Statement on Form S-8 (this “Registration Statement”) with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), to register (i) 42,300,000 shares of the Company’s common stock, par value $.001 per share (“Common Stock”), that may be issued under the 2025 Genworth Financial, Inc. Omnibus Incentive Plan (the “Plan”); and (ii) such additional shares that may become issuable in accordance with the adjustment and anti-dilution provisions of the Plan.

    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    (a) The documents constituting Part I of this Registration Statement will be delivered to participants in the Plan as specified by Rule 428(b)(1) under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of this form, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

    (b) Upon written or oral request, the Company will provide, without charge, the documents incorporated by reference in Item 3 of Part II of this Registration Statement. The documents are incorporated by reference in the Section 10(a) prospectus. The Company will also provide, without charge, upon written or oral request, other documents required to be delivered to employees pursuant to Rule 428(b). Requests for the abovementioned information should be directed to Investor Relations, Genworth Financial, Inc., 11011 West Broad Street, Glen Allen, Virginia 23060 at [email protected].

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3.

    Incorporation of Documents by Reference.

    The following documents, filed with the Commission by the Company pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are incorporated herein by reference:

     

      (a)

    The Company’s Annual Report on Form 10-K for the year ended December 31, 2024;

     

      (b)

    The Company’s Current Reports on Form 8-K (excluding any information and exhibits furnished under Item 2.02 or 7.01 thereof) filed with the Commission on March  19, 2025, and May 22, 2025;

     

      (c)

    All other reports filed by the Company pursuant to Section 13(a) or 15(d) of the Exchange Act since December 31, 2024 (except to the extent any parts of such reports were deemed furnished and not filed in accordance with SEC rules);

     

      (d)

    The description of the Company’s Capital Stock contained in the Company’s Current Report on Form 8-K filed with the Commission on June 7, 2024, and any amendment or report filed for the purpose of further updating such description; and

     

      (e)

    All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities that remain unsold.


    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

    Item 4.

    Description of Securities.

    Not applicable.

     

    Item 5.

    Interests of Named Experts and Counsel.

    Not applicable.

     

    Item 6.

    Indemnification of Directors and Officers.

    Section 145 of the Delaware General Corporation Law (the “DGCL”) provides that a corporation may indemnify directors and officers, as well as other employees and individuals, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent of such corporation. The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any certificate of incorporation, bylaws, agreement, vote of stockholders or disinterested directors or otherwise.

    Section 102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for payments of unlawful dividends or unlawful stock repurchases, redemptions or other distributions, or (iv) for any transactions from which the director derived an improper personal benefit.

    The amended and restated certificate of incorporation of the Company provides that the Company will indemnify its directors and officers to the fullest extent permitted by law and that no director shall be liable for monetary damages to the Company or its stockholders for any breach of fiduciary duty, except to the extent provided by applicable law.

    The Company maintains policies of directors’ and officers’ liability insurance.

    In addition, the Company has entered into separate indemnification agreements with certain of its current and former directors and executive officers. The indemnification agreements provide generally that the Company will indemnify and advance expenses to the fullest extent permitted by applicable law. Each director and executive officer party to an indemnification agreement is entitled to be indemnified against all expenses, judgments, penalties and amounts paid in settlement actually and reasonably incurred.

     

    Item 7.

    Exemption from Registration Claimed.

    Not applicable.


    Item 8.

    Exhibits.

    Except as indicated below as being incorporated by reference to another filing with the Commission by the Registrant, the following exhibits to this registration statement are being filed herewith:

     

    Exhibit
    Number

      

    Description

     4.1    Amended and Restated Certificate of Incorporation of Genworth Financial, Inc., effective as of June  6, 2024 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on June 7, 2024)
     4.2    Amended and Restated Bylaws of Genworth Financial, Inc., effective as of October  18, 2024 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K/A filed on October 22, 2024)
     4.3    Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on June 7, 2024)
     4.4    Description of the Company’s Capital Stock (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed on June 7, 2024)
     5.1    Opinion of Alston & Bird LLP
    23.1    Consent of Alston & Bird LLP (included in Exhibit 5.1)
    23.2    Consent of KPMG LLP
    24.1    Power of Attorney
    99.1    2025 Genworth Financial, Inc. Omnibus Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 7, 2025)
    107    Filing Fee Table

     

    Item 9.

    Undertakings.

    (a) The Company hereby undertakes:

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective registration statement; and

    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

    Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the registration statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Company pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.


    (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    (b) The undersigned Company hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Company’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

    (Signatures on following page)


    SIGNATURES

    The Registrant. Pursuant to the requirements of the Securities Act of 1933, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the county of Henrico, state of Virginia, on this 28th day of May, 2025.

     

    GENWORTH FINANCIAL, INC.
    By:  

    /s/ Thomas J. McInerney

      Thomas J. McInerney
      President and Chief Executive Officer


    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature

      

    Title

     

    Date

    /s/ Thomas J. McInerney

    Thomas J. McInerney

       President and Chief Executive Officer; Director (Principal Executive Officer)   May 28, 2025

    /s/ Jerome T. Upton

    Jerome T. Upton

      

    Executive Vice President and

    Chief Financial Officer (Principal Financial Officer)

      May 28, 2025

    /s/ Darren W. Woodell

    Darren W. Woodell

      

    Vice President and Controller

    (Principal Accounting Officer)

      May 28, 2025

    *

    Melina E. Higgins

       Non-Executive Chair of the Board and Director   May 28, 2025

    *

    G. Kent Conrad

       Director   May 28, 2025

    *

    Karen E. Dyson

       Director   May 28, 2025

    *

    Jill R. Goodman

       Director   May 28, 2025

    *

    Howard D. Mills, III

       Director   May 28, 2025

    *

    Robert P. Restrepo Jr.

       Director   May 28, 2025

    *

    Elaine A. Sarsynski

       Director   May 28, 2025

    *

    Ramsey D. Smith

       Director   May 28, 2025

    *

    Steven C. Van Wyk

       Director   May 28, 2025

    *By: /s/ Thomas J. McInerney

    Thomas J. McInerney

        
    Attorney-in-Fact     

     

    Get the next $GNW alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO; Director Mcinerney Thomas J gifted 150,000 shares, decreasing direct ownership by 3% to 4,727,910 units (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/28/25 4:18:26 PM ET
      $GNW
      Life Insurance
      Finance
    • Director Van Wyk Steven C. was granted 45,576 shares (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:24:22 PM ET
      $GNW
      Life Insurance
      Finance
    • Director Smith Ramsey D. was granted 23,681 shares, increasing direct ownership by 47% to 74,391 units (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:24:07 PM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Financials

    Live finance-specific insights

    See more
    • Genworth Financial Schedules Earnings Conference Call for July 31

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on July 30, 2025. A conference call will be held on July 31, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's July 31 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #8808137. To participate in the cal

      7/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Schedules Earnings Conference Call for May 1

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on April 30, 2025. A conference call will be held on May 1, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 1 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #3161071. To participate in the call by

      4/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Genworth Financial Inc

      SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      10/25/24 3:16:06 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

      SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

      2/13/24 5:06:12 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SC 13G filed by Genworth Financial Inc

      SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      2/9/24 9:59:00 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Genworth Financial upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

      6/18/25 7:44:47 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    SEC Filings

    See more
    • SEC Form 11-K filed by Genworth Financial Inc

      11-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

      6/23/25 4:07:24 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form S-8 filed by Genworth Financial Inc

      S-8 - GENWORTH FINANCIAL INC (0001276520) (Filer)

      5/28/25 4:16:43 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form 8-K filed by Genworth Financial Inc

      8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

      5/22/25 4:16:10 PM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genworth Financial Schedules Earnings Conference Call for July 31

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing second quarter results after the market closes on July 30, 2025. A conference call will be held on July 31, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's July 31 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #8808137. To participate in the cal

      7/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $GNW
    Leadership Updates

    Live Leadership Updates

    See more
    • CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

      CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

      2/13/24 8:30:00 AM ET
      $GNW
      Life Insurance
      Finance
    • Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

      RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

      1/4/21 7:00:00 AM ET
      $GNW
      Life Insurance
      Finance